The global knotless tissue control devices market is experiencing dynamic growth, with recent market research forecasting a robust Compound Annual Growth Rate (CAGR) of 3.4% from 2022 to 2032. Starting at a valuation of USD 465.6 million in 2022, the market is projected to reach an impressive USD 672.6 million by 2032, underscoring a transformative shift in modern surgical practices.
This growth trajectory is largely fueled by the rising adoption of minimally invasive procedures, driven by their well-documented benefits, including shorter recovery times, less pain, and a significantly lower risk of post-surgical complications. Both healthcare professionals and patients are increasingly favoring these advanced techniques, positioning knotless tissue control devices as a critical component in the evolution of surgical care.
“Knotless tissue control devices are revolutionizing how surgeries are performed, offering unparalleled precision and reliability in tissue manipulation,” said FMI. “These devices eliminate the need for traditional sutures, making them indispensable in minimally invasive procedures that prioritize patient outcomes and satisfaction.”
Advancing Healthcare Through Technology:
The market’s expansion is further bolstered by continuous technological innovations that enhance the design and functionality of knotless tissue control devices. These advancements enable surgeons to perform increasingly complex procedures with greater accuracy and efficiency, thereby broadening the scope of surgeries achievable through minimally invasive methods.
As a cornerstone of contemporary healthcare, minimally invasive procedures are reshaping surgical norms, prioritizing reduced trauma and faster healing. Knotless tissue control devices are at the forefront of this paradigm shift, delivering enhanced surgical outcomes and elevating patient care standards.
Future Outlook:
With healthcare systems worldwide embracing the advantages of minimally invasive techniques, the knotless tissue control devices market is well-positioned for sustained growth. The integration of cutting-edge technology and a growing demand for patient-centric solutions are expected to propel the market to new heights over the next decade.
The global knotless tissue control devices market is being driven by several key factors:
- Benefits of Knotless Tissue Control Devices: Knotless tissue control devices offer various benefits such as distributing tension along the wound, simplifying knot tying, and reducing knot-related complications. These advantages are expected to increase the demand for these devices in healthcare settings.
- Rising Number of Surgical Procedures: An increasing number of surgical procedures, including knee replacements, bypass surgeries, hip replacements, and cosmetic surgeries, are anticipated to drive the demand for knotless tissue control devices. As the population ages and the prevalence of conditions requiring surgical intervention rises, the demand for these devices is expected to grow correspondingly.
- Demographic Trends: The aging population is particularly relevant to the demand for knotless tissue control devices. A study published by the National Centre for Biotechnology Information indicates that approximately 30% of elderly individuals fall due to difficulties in walking, which often necessitates knee replacement surgeries. As the population continues to age globally, the need for such surgical procedures is expected to increase, further driving the demand for knotless tissue control devices.
- Technological Advancements and Product Innovation: The launch of efficient devices by key players in the market is expected to strengthen the industry. For example, Smith & Nephew launched HELICOIL knotless sutures in September 2020, which utilize bone marrow and associated stem cells to enhance the healing process. Such innovations enhance the effectiveness and usability of knotless tissue control devices, contributing to market growth.
Overall, the convergence of these factors is expected to fuel the growth of the global knotless tissue control devices market in the foreseeable future.
Gain Full Insight: Access the Complete Knotless Tissue Control Devices Market Report
Competitive Landscape:
The global knotless tissue control devices market is shaped by prominent players such as Johnson & Johnson Services, Inc., Medtronic, Ethicon USA, LLC (a subsidiary of Johnson & Johnson), and Medline Industries, Inc.
- Medtronic, a leader in healthcare technology, announced in July 2022 that it had entered into a strategic agreement with CathWorks, an Israel-based company dedicated to revolutionizing the diagnosis and treatment of coronary artery disease (CAD).
- In June 2021, Blackstone, Carlyle, and Hellman & Friedman completed the acquisition of Medline Industries, a Northfield, Illinois-based company, for a remarkable USD 30 billion. Medline is recognized as the largest privately held manufacturer and distributor of healthcare supplies.
Top of Form
Key Segments Profiled in the Global Knotless Tissue Control Devices Market:
By Product Type:
- Short-Term
- Long-Term
- Nonabsorbable Polymers
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Trauma Centers
- Medical Device Manufacturers
- Pharmaceutical Companies
- Research Centers and Laboratory
By Region:
- North American
- Latin American
- Western European
- Eastern European
- Asia-Pacific
- Japanese
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube